Παρακολούθηση
Fatima Cardoso
Fatima Cardoso
Breast Unit, Champalimaud Clinical Center, Champalimaud Foundation, Lisbon, Portugal
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα fundacaochampalimaud.pt
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
46502013
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F Cardoso, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 30 (8), 1194-1220, 2019
27952019
Pembrolizumab for early triple-negative breast cancer
P Schmid, J Cortes, L Pusztai, H McArthur, S Kümmel, J Bergh, C Denkert, ...
New England Journal of Medicine 382 (9), 810-821, 2020
24562020
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis
C Sotiriou, P Wirapati, S Loi, A Harris, S Fox, J Smeds, H Nordgren, ...
Journal of the National Cancer Institute 98 (4), 262-272, 2006
23772006
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
23692015
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ...
Annals of oncology 26, v8-v30, 2015
21422015
70-gene signature as an aid to treatment decisions in early-stage breast cancer
F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ...
New England Journal of Medicine 375 (8), 717-729, 2016
20452016
Current and future burden of breast cancer: Global statistics for 2020 and 2040
M Arnold, E Morgan, H Rumgay, A Mafra, D Singh, M Laversanne, ...
The Breast 66, 15-23, 2022
20322022
Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer
M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ...
Journal of the National Cancer Institute 98 (17), 1183-1192, 2006
15442006
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
J Cortes, J O'Shaughnessy, D Loesch, JL Blum, LT Vahdat, K Petrakova, ...
The Lancet 377 (9769), 914-923, 2011
13782011
Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients
E de Azambuja, F Cardoso, G de Castro, M Colozza, MS Mano, ...
British journal of cancer 96 (10), 1504-1513, 2007
13692007
4th ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 4)
F Cardoso, E Senkus, A Costa, E Papadopoulos, M Aapro, F André, ...
Annals of Oncology 29 (8), 1634-1657, 2018
13322018
De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
13302017
5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)
F Cardoso, S Paluch-Shimon, E Senkus, G Curigliano, MS Aapro, F André, ...
Annals of Oncology 31 (12), 1623-1649, 2020
12492020
Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series
C Desmedt, F Piette, S Loi, Y Wang, F Lallemand, B Haibe-Kains, G Viale, ...
Clinical cancer research 13 (11), 3207-3214, 2007
11032007
Extracellular vesicle and particle biomarkers define multiple human cancers
A Hoshino, HS Kim, L Bojmar, KE Gyan, M Cioffi, J Hernandez, ...
Cell 182 (4), 1044-1061. e18, 2020
9942020
3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017
9392017
Event-free survival with pembrolizumab in early triple-negative breast cancer
P Schmid, J Cortes, R Dent, L Pusztai, H McArthur, S Kümmel, J Bergh, ...
New England Journal of Medicine 386 (6), 556-567, 2022
9042022
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
F Cardoso, A Costa, L Norton, E Senkus, M Aapro, F Andre, CH Barrios, ...
The Breast 23 (5), 489-502, 2014
8732014
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
E Senkus, S Kyriakides, F Penault-Llorca, P Poortmans, A Thompson, ...
Annals of oncology 24, vi7-vi23, 2013
7302013
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20